GlassScriptPhysician profile
David S Osteen
NPI 1881656163
$198.86
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $16.37 · 2021: $47.82.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $49.25 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $41.29 | 2019 | |
| Innovation Technologies INC | $19.00 | 2021 | |
| Pfizer INC. | $17.77 | 2019 | |
| Ermi LLC | $16.37 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $15.27 | 2019 | |
| Wright Medical Technology, INC. | $14.82 | 2019 | |
| Ethicon US, LLC | $13.55 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $11.54 | 2019 |
2 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Osteen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.